Usefulness of Low-Dose Splenic Irradiation prior to Reduced-Intensity Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Elderly Patients with Myelofibrosis
The Janus kinase (JAK) 1 and 2 inhibitor, ruxolitinib, was recently approved in Japan and has been effective in many patients with myelofibrosis (MF). Although the inhibitor decreases splenomegaly and relieves MF-related symptoms, allogeneic hematopoietic cell transplantation (HCT) remains as the on...
Saved in:
Main Authors: | Etsuko Matsubara, Jun Yamanouchi, Riko Kitazawa, Taichi Azuma, Hiroshi Fujiwara, Takaaki Hato, Masaki Yasukawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2016/8751329 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reconstructing skeletal homeostasis through allogeneic hematopoietic stem cell transplantation in myelofibrosis
by: Mathias Schäfersküpper, et al.
Published: (2025-01-01) -
Effect of Hematopoietic Stem Cell Transplantation Regimen on Tacrolimus Pharmacokinetics
by: Haruno Oku, BS, et al.
Published: (2025-01-01) -
Chronic Lymphocytic Leukemia and Myelofibrosis
by: Fares Darawshy, et al.
Published: (2018-01-01) -
Successful Control of Acute Myelofibrosis with Lenalidomide
by: G. Vassilopoulos, et al.
Published: (2010-01-01) -
Dermatomyositis Associated with Myelofibrosis following Polycythemia Vera
by: Naomi Fei, et al.
Published: (2017-01-01)